Edition:
United States

vTv Therapeutics Inc (VTVT.OQ)

VTVT.OQ on NASDAQ Stock Exchange Capital Market

2.72USD
22 Jan 2019
Change (% chg)

-- (--)
Prev Close
$2.72
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
658,674
52-wk High
$8.37
52-wk Low
$0.65

Chart for

About

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of orally administered small molecule drug candidates. Its drug candidate for the treatment of Alzheimer's disease (AD) is azeliragon (TTP488), an orally administered, small molecule antagonist targeting... (more)

Overall

Beta: -3.44
Market Cap(Mil.): $67.64
Shares Outstanding(Mil.): 40.75
Dividend: --
Yield (%): --

Financials

  VTVT.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.52 -- --
ROI: -- 0.60 13.80
ROE: -- -2.18 15.29

Earnings vs. Estimates